A modern view of prostate biopsy

Cover Page

Cite item

Full Text

Abstract

Active introduction of programs for early diagnosis of prostate cancer, including the implementation of digital rectal examination, determination of prostate-specific antigen and transrectal ultrasound made it possible to identify the disease at an early stage and offer patients radical treatment. Currently, in addition to the standardized cancer diagnostic methods of prostate cancer, patients may be asked a lot of non-invasive diagnostic methods: the definition of the prostate health index, the PCA3 (Prostate Cancer gene 3), carrying out magnetic resonance imaging, various fusion technology, as well as varieties of prostate ultrasound (histoscanning, sonoelastography, etc.). The emergence of new non-invasive imaging techniques has shown considerable potential in diagnosing prostate cancer, choosing a method of treatment, planning the course of the operation and subsequently monitoring patients.

About the authors

A. A Demin

A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

Email: lavahead@mail.ru
аспирант каф. урологии 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

A. V Govorov

A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

Email: dr.govorov@gmail.com
д-р мед. наук, проф. каф. урологии 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

A. O Vasilyev

A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

Email: alexvasilyev@me.com
канд. мед. наук, ассистент каф. урологии 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

A. V Okishev

A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

Email: okishev.art@gmail.com
ординатор каф. урологии 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

Yu. A Kim

A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

Email: dockimyura@gmail.com
ординатор каф. урологии 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

D. Yu Pushkar

A.I.Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of the Russian Federation

Email: pushkardm@mail.ru
127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1

References

  1. Rebecca L, Siegel M.P.H, Kimberly D et al. Cancer statistics. Cancer J Clin 2018; 68: 7-30.
  2. Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). Под ред. А.Д.Каприна, В.В.Старинского, Г.В.Петровой. М.: МНИОИ им. П.А.Герцена - филиал ФГБУ «НМИРЦ» Минздрава России, 2017.
  3. Mettlin C, Murphy G.P, Babaian R.J et al. The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer 1996; 77(1): 150-9.
  4. Xue J, Qin Z, Cai H et al. Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis. Oncotarget 2017; 8 (14): 23322-36.
  5. Guichard G, Larreґ S, Gallina A et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol 2007; 52: 430-5.
  6. Berger A.P, Gozzi C, Steiner H et al. Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. J Urol 2004; 171: 1478-80.
  7. Gao Y, Liao X.H, Lu L et al. Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer. Clin Radiol 2016; 71 (3): 258-64.
  8. Rohrbach D, Wodlinger B, Wen J et al. High-Frequency Quantitative Ultrasound for Imaging Prostate Cancer Using a Novel Micro-Ultrasound Scanner. Ultrasound Med Biol 2018; 4: S0301-5629(18)30080-2.
  9. Ghai S, Eure G, Fradet V. Assessing Cancer Risk on Novel 29 MHz Micro-Ultrasound Images of the Prostate: Creation of the Micro-Ultrasound Protocol for Prostate Risk Identification. J Urol 2016; 196 (2): 562-9.
  10. Ghai S, Van der Kwast T. Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer. Urol Case Reports 2018; 16: 98-100.
  11. Salomon G, Schiffmann J. Real-time elastography for the detection of prostate cancer. Curr Urol Rep 2014; 15: 392.
  12. Aigner F, Pallwein L, Junker D et al. Value of real-time elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 1.25 ng/ml or greater and 4.00 ng/ml or less. J Urol 2010; 184: 913-7.
  13. Salomon G, Drews N, Autier P et al. Incremental detection rate of prostate cancer by real-time elastography targeted biopsies in combination with a conventional 10-core biopsy in 1024 consecutive patients. BJU Int 2014; 113: 548-53.
  14. Boehm K, Salomon G, Beyer B et al. Shear wave elastography for localization of prostate cancer lesions and assessment of elasticity thresholds: implications for targeted biopsies and active surveillance protocols. J Urol 2015; 193: 794-800.
  15. Васильев А.О., Говоров А.В., Пушкарь Д.Ю. Гистосканирование предстательной железы у пациентов, перенесших криоаблацию простаты. Качество. Инновации. Образование. Научно-практическая конференция «Роботические технологии в медицине». 2016: 9-14.
  16. Braeckman J, Autier P, Garbar C et al. Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int 2008; 101: 293-8.
  17. Говоров А.В., Васильев А.О., Садченко А.В. и др. Роль гистосканирования предстательной железы в выявлении рака простаты. Consilium Medicum. 2015; 17 (7): 8-11.
  18. Schiffmann J, Tennstedt P, Fischer J et al. Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate. World J Urol 2014; 32: 925-30.
  19. Glybochko P.V, Alyaev Y.G, Amosov A.V et al. Evaluation of Prostate HistoScanning as a Method for Targeted Biopsy in Routine Practice. Eur Urol Focus 2017; 19: S2405-4569(17)30172-4.
  20. Hamann M.F, Meyer D, Knüpfer S. Application of ultrasound imaging biomarkers (HistoScanning™) improves staging reliability of prostate biopsies. BMC Res Notes 2017; 10 (1): 579.
  21. Bratan F, Niaf E, Melodelima C et al. Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 2013; 23: 2019.
  22. Wegelin O, van Melick H.H.E, Hooft L et al. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique? Eur Urol 2017; 71 (4): 517-31.
  23. Friedl A, Schneeweiss J, Sevcenco S et al. In-bore 3.0-T Magnetic Resonance Imaging-guided Transrectal Targeted Prostate Biopsy in a Repeat Biopsy Population: Diagnostic Performance, Complications, and Learning Curve. Urology 2018; 114: 139-46.
  24. Baco E, Ukimura O, Rud E et al. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Eur Urol 2015; 67: 787-94.
  25. Dickinson L, Hu Y, Ahmed H.U et al. Image-directed, tissue-preserving focal therapy of prostate cancer: a feasibility study of a novel deformable magnetic resonance-ultrasound (MR-US) registration system. BJU Int 2013; 112: 594-601.
  26. Da Rosa M.R, Milot L, Sugar L et al. A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance. J Magn Reson Imaging 2015; 41: 220-5.
  27. Kasivisvanathan V, Rannikko A.S, Borghi M et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med 2018.
  28. Lopci E, Saita A, Lazzeri M et al. 68Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study. J Urol 2018; pii: S0022-5347(18)30172-1.
  29. Valerio M, Donaldson I, Emberton M et al. Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review. Eur Urol 2015; 68 (1): 8-19.

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies